#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Breast cancer metastatic Hepatocellular carcinoma Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Type 2 diabetes mellitus Chronic lymphocytic leukaemia More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glycogen storage disease type I Non-renal cell carcinoma of kidney B-cell lymphoma refractory Gastric cancer Transitional cell cancer of the renal pelvis and ureter CDKL5 deficiency disorder Haemophilia A with anti factor VIII Indolent systemic mastocytosis Fungal infection Pyoderma gangrenosum Hereditary angioedema Cutaneous T-cell lymphoma Drug eruption Hyperchylomicronaemia Cytomegalovirus infection More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma – Treatment Atypical haemolytic uraemic syndrome – Diagnostics Langerhans’ cell histiocytosis – Life with Disease Shprintzen-Goldberg syndrome Paroxysmal nocturnal haemoglobinuria – Trials in Disease Thrombotic thrombocytopenic purpura – Basic Information Richter’s syndrome – Trials in Disease Gastrointestinal stromal tumour – Diagnostics Mucous membrane pemphigoid – Trials in Disease Krabbe’s disease – Life with Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Goserelin Mbf-118 Lidocaine Vortioxetine Chlorphenamine Maleate Pantoprazole Amoxicillin Sodium Bempedoic Acid Topiramate Iomeprol Thiotepa Vilobelimab Salbutamol Psma-11 Metolazone Azilsartan Medoxomil Tobramycin Bictegravir Valganciclovir Hydrochloride Pristinamycin More therapies…

    Learn about Your Condition

    Myocarditis Meniere's disease Factor VIII deficiency Osteomyelitis Pulmonary fibrosis Bronchostenosis Tooth loss Alport's syndrome Lymphangioma Pulmonary tuberculosis Medication overuse headache Haematological infection Seizure Round cell liposarcoma Cerebellar ataxia More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hormone receptor positive breast cancer

  • Study Comparing DB-1303 and Chemotherapy for Patients with HER2-low, Hormone Receptor Positive, Metastatic Breast Cancer

    Not recruiting

    1 1 1 1
    Investigated drugs:
    • Db-1303
    • Paclitaxel Albumin-Bound
    • Capecitabine
    Belgium France Germany Hungary Italy Poland +1

  • Study of palbociclib with hormone therapy versus hormone therapy alone in patients with recurrent hormone receptor-positive/HER2-negative breast cancer after surgery

    Not recruiting

    1 1 1 1
    Investigated diseases:
    • Breast cancer recurrent
    • Hormone receptor positive breast cancer
    • HER2 negative breast cancer
    Investigated drugs:
    • Palbociclib
    Austria France Hungary Italy Spain

  • Study of JK08, Pembrolizumab, and Lenvatinib for Patients with Advanced or Metastatic Cancer

    Not recruiting

    1 1 1
    Investigated diseases:
    • Clear cell papillary renal cell carcinoma
    • Endometrial adenocarcinoma
    • Oesophageal squamous cell carcinoma
    Investigated drugs:
    • Jk08
    • Lenvatinib
    • Pembrolizumab
    Belgium Spain

  • Study on Giredestrant and Everolimus for Patients with Estrogen Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer

    Not recruiting

    1 1 1 1
    Investigated drugs:
    • Giredestrant
    • Tamoxifen Citrate
    • Exemestane
    Germany Greece Italy Spain

  • Study to Improve Tolerance of Sacituzumab Govitecan with Loperamide and Filgrastim in Patients with Advanced Triple-Negative or Luminal Breast Cancer

    Not recruiting

    1 1 1
    Investigated diseases:
    • Hormone receptor positive breast cancer
    • Triple negative breast cancer
    Investigated drugs:
    • Sacituzumab Govitecan
    • Filgrastim
    • Loperamide Hydrochloride
    Spain

  • Study of ribociclib combined with hormone therapy for patients with early-stage hormone receptor-positive, HER2-negative breast cancer

    Not recruiting

    1 1 1 1
    Investigated drugs:
    • Anastrozole
    • Goserelin
    • Letrozole
    Austria Belgium France Germany Hungary Ireland +4
Previous Page
1 … 3 4 5 6 7
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!